Position in PFE
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$139,855,023
+$24,069,227 QoQ
Shares Held
4,980,592
+7.1% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.74%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026AustralianSuper Pty Ltd holds $954,613,199 across 8 Drug Manufacturers - General names. PFE ranks #3 (14.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
276,856 | $254,643,843 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
1,436,171 | $200,159,152 | |
| 3 | PFE |
Pfizer Inc
This page
|
4,980,592 | $139,855,023 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
2,125,356 | $128,902,841 | |
| 5 | BIIB |
Biogen Inc.
|
616,193 | $112,966,662 | |
| 6 | MRK |
Merck & Co., Inc.
|
575,397 | $69,214,505 | |
| 7 | ABBV |
AbbVie Inc.
|
204,149 | $44,400,366 | |
| 8 | JNJ |
Johnson & Johnson
|
18,290 | $4,470,807 |
All Filings in PFE
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $139,855,023 | 4,980,592 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $115,785,796 | 4,650,032 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $101,379,161 | 3,978,774 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $55,833,422 | 2,303,359 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $8,005,767 | 315,934 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $8,381,729 | 315,934 | Shares | Sole | 2025-01-30 | |
| 2024-03-31 | $86,949,408 | 3,133,312 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $26,917,786 | 934,970 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $103,402,632 | 3,117,354 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $99,000,126 | 2,699,022 | Shares | Sole | 2023-07-28 | |
| 2022-12-31 | $126,967,391 | 2,477,896 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $100,624,763 | 2,299,469 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $26,828,974 | 518,234 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $13,686,313 | 231,775 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $20,035,520 | 465,834 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $12,367,863 | 315,829 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $11,291,876 | 311,672 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $69,411,107 | 1,885,659 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $59,774,770 | 1,716,694 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $52,255,584 | 1,684,322 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $54,010,146 | 1,744,080 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||